ibuprofen has been researched along with Vasospasm, Intracranial in 3 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Vasospasm, Intracranial: Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibuprofen was incorporated into ethylene-vinyl acetate (EVAc) polymers at 45% loading (wt:wt)." | 5.33 | Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage. ( Clatterbuck, RE; Gailloud, P; Legnani, FG; Murphy, KP; Pradilla, G; Tamargo, RJ; Thai, QA, 2005) |
| "Ibuprofen is an antiinflammatory agent that inhibits the expression of specific cell adhesion molecules and, consequently, disrupts leukocyte-endothelial cell interactions." | 5.32 | Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage. ( Frazier, JL; Pradilla, G; Tamargo, RJ; Wang, PP, 2004) |
| "Ibuprofen was incorporated into ethylene-vinyl acetate (EVAc) polymers at 45% loading (wt:wt)." | 1.33 | Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage. ( Clatterbuck, RE; Gailloud, P; Legnani, FG; Murphy, KP; Pradilla, G; Tamargo, RJ; Thai, QA, 2005) |
| "Ibuprofen is an antiinflammatory agent that inhibits the expression of specific cell adhesion molecules and, consequently, disrupts leukocyte-endothelial cell interactions." | 1.32 | Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage. ( Frazier, JL; Pradilla, G; Tamargo, RJ; Wang, PP, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dayyani, M | 1 |
| Mousavi Mohammadi, E | 1 |
| Ashoorion, V | 1 |
| Sadeghirad, B | 1 |
| Javedani Yekta, M | 1 |
| Grotta, JC | 1 |
| Gonzalez, NR | 1 |
| Zabihyan, S | 1 |
| Frazier, JL | 1 |
| Pradilla, G | 2 |
| Wang, PP | 1 |
| Tamargo, RJ | 2 |
| Thai, QA | 1 |
| Legnani, FG | 1 |
| Clatterbuck, RE | 1 |
| Gailloud, P | 1 |
| Murphy, KP | 1 |
1 trial available for ibuprofen and Vasospasm, Intracranial
| Article | Year |
|---|---|
Aneurysmal subarachnoid haemorrhage-cerebral vasospasm and prophylactic ibuprofen: a randomised controlled pilot trial protocol.
Topics: Adolescent; Adult; Humans; Ibuprofen; Pilot Projects; Randomized Controlled Trials as Topic; Subarac | 2022 |
2 other studies available for ibuprofen and Vasospasm, Intracranial
| Article | Year |
|---|---|
Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Basilar Artery; Cisterna Magna; Disease Models, An | 2004 |
Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage.
Topics: Animals; Cerebral Angiography; Delayed-Action Preparations; Disease Models, Animal; Ibuprofen; Macac | 2005 |